09:00 ET from Torax Medical, Inc.
ST. PAUL, Minn., April 7, 2016 /PRNewswire/ -- Torax Medical, Inc., a leader in devices to treat sphincter-related diseases, including gastroesophageal reflux disease (GERD), announced today that Health Care Service Corporation (HCSC), the 4thlargest commercial health insurer in the U.S., has issued a medical coverage policy for the LINX® Reflux Manag...
Read More
The Importance of a Full Workup for GERD Patients
Dr. Tsai reviews the various tests that chronic heartburn or gastroesophageal reflux disease (GERD) sufferers can take to determine the root cause of their symptoms.
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode...
Read More
Heartburn Medicine Linked to Chronic Kidney Disease Risk, Study Shows
NBC Nightly News with Lester Holt
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-8301260...
Read More
Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett’s esophagus
Puya Gharahkhani1,* Joyce Tung3, David Hinds3, Aniket Mishra1,4 Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), Thomas L. Vaughan5, David C. Whiteman2 and Stuart MacGregor1 on behalf of the BEACON study investigators
Author Affiliations
1Statistical Genetics Laboratory
2Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia
323andMe, Mount...
Read More
Reflux Revisited
January 19, 2016
Published by 23andMe under 23andMe Research, Uncategorized
A recently published study by scientists at Australia’s QIMR Berghofer Medical Research Institute could have a significant
impact on the study of esophageal adenocarcinoma, a rare but lethal form of cancer.
Along with esophageal cancer, the study looked at two other conditions that often are overlapping o...
Read More
Proton pump inhibitors alter the composition of the gut microbiota
Abstract
Objective Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and treat GI disorders such as peptic ulcers and gastro-oesophageal reflux. They have been considered low risk, have been widely adopted, and are often over-prescribed. Recent studies have identified an increased risk of enteric and other infections with their use. Small studies have identif...
Read More
American Medical Association Creates New Category 1 Code for Torax Medical’s LINX Procedure to Treat Gastroesophageal Reflux Disease
November 18, 2015 05:00 AM Eastern Standard Time
ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related diseases, including gastroesophageal reflux disease (GERD), announced today the American Medical Association (AMA) has created a new Category 1 Current Procedural Terminology (CPT®) Code for esophageal sphincter augmentation using ...
Read More